<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In five head-injured patients with cerebral <z:mp ids='MP_0009275'>contusion</z:mp> and <z:hpo ids='HP_0000969'>oedema</z:hpo> in whom it was not possible to control ICP by <z:hpo ids='HP_0002883'>hyperventilation</z:hpo> and <z:chebi fb="8" ids="29745">barbiturate</z:chebi> sedation, <z:chebi fb="0" ids="49662">indomethacin</z:chebi> Confortid was used as a cerebral vasoconstrictor drug </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> patients <z:chebi fb="0" ids="49662">indomethacin</z:chebi> reduced ICP below 20 mmHg for several hours </plain></SENT>
<SENT sid="2" pm="."><plain>Studies of cerebral circulation and metabolism during <z:chebi fb="0" ids="49662">indomethacin</z:chebi> treatment showed a decrease in cerebral blood flow (CBF) at 2 hours </plain></SENT>
<SENT sid="3" pm="."><plain>After 7 hours </plain></SENT>
<SENT sid="4" pm="."><plain>ICP remained below 20 mmHg in three patients, and these still had reduced CBF </plain></SENT>
<SENT sid="5" pm="."><plain>In two patients a return of ICP and CBF to pretreatment levels was observed </plain></SENT>
<SENT sid="6" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> patients <z:chebi fb="0" ids="49662">indomethacin</z:chebi> treatment was followed by a fall in rectal temperature </plain></SENT>
<SENT sid="7" pm="."><plain>Outcome scaling has not yet been performed, but <z:hpo ids='HP_0000001'>all</z:hpo> patients left hospital without neurological deficits </plain></SENT>
<SENT sid="8" pm="."><plain>These results suggest that <z:chebi fb="0" ids="49662">indomethacin</z:chebi> is an alternative in the treatment of intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> in head-injured patients </plain></SENT>
</text></document>